Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Paclitaxel/Oxaliplatin/Fluorouracil (TOF) Regimen Versus S-1/Oxaliplatin (SOX) Regimen Metastatic Gastric Cancer Patients

NCT02442362 is registered in ClinicalTrials.gov with The First People's Hospital of Changzhou as lead sponsor.

NCT NCT02442362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02442362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Paclitaxel/Oxaliplatin/Fluorouracil (TOF) Regimen Versus S-1/Oxaliplatin (SOX) Regimen Metastatic Gastric Cancer Patients
Lead sponsor
The First People's Hospital of Changzhou
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2014
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer